As of 2026-07-19, the Relative Valuation of Ultragenyx Pharmaceutical Inc (RARE) is (143.74) USD. This relative valuation is based on P/E multiples. With the latest stock price at 29.28 USD, the upside of Ultragenyx Pharmaceutical Inc based on Relative Valuation is -590.9%.
The range of the Relative Valuation is (138.49) - (142.82) USD.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | 22.2x - 25.3x | 23.8x |
| Forward P/E multiples | 22.4x - 23.1x | 22.8x |
| Fair Price | (138.49) - (142.82) | (143.74) |
| Upside | -573.0% - -587.8% | -590.9% |
| Date | P/E |